U.S. eyes Israeli military data for Pfizer COVID-19 booster safety

France Nouvelles Nouvelles

U.S. eyes Israeli military data for Pfizer COVID-19 booster safety
France Dernières Nouvelles,France Actualités
  • 📰 Reuters
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 97%

U.S. health officials are hoping data on Israeli military personnel can help clarify the risk of heart muscle inflammation in younger people who have received Pfizer/BioNTech COVID-19 booster shots - a potential factor for U.S. regulators as they consider granting full approval of these boosters.

"The real question that we have not yet answered is the safety data of an mRNA in young people vis-a-vis myocarditis," Dr. Anthony Fauci, President Joe Biden's chief medical adviser and the top U.S. infectious disease expert, said in a telephone interview.

The U.S. Food and Drug Administration in August granted full approval for the Pfizer/BioNTech vaccine for people age 16 and older but the agency has not yet given full approval for its use as a booster shot. Instead, the FDA approved Pfizer's booster under an emergency use authorization with approval on the full biologics license application still pending.

Fauci said the Israel military data should help address the gap in safety information on mRNA vaccines, "which is one of the things that the advisory committee was interested in." Fauci said he expects data from Israeli military recruits specifically to shed light on the safety of the vaccines in younger people in the context of myocarditis.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Reuters /  🏆 2. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Covid-19 Deaths in U.S. Level Off as Delta Variant Surge EasesThe seven-day average for daily new Covid-19 deaths in the U.S. has hovered near 2,000 for more than a week, after a two-month climb during which more than 80,000 additional deaths were reported.
Lire la suite »

Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sectorMerck COVID-19 pill success slams Moderna shares, shakes up healthcare sectorPositive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the healthcare sector on Friday, sending the drugmaker's stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies.
Lire la suite »

School Boards Ask for Federal Help as Tensions Rise Over Covid-19 PoliciesAn organization representing school boards across the U.S. is asking the federal government for help in response to threats and harassment over Covid-19 protocols in schools
Lire la suite »



Render Time: 2025-03-16 13:40:30